Pharmacy Board Warns Kenyans Against Misusing Cetirizine for Vaginal Tightening
Kenya’s Pharmacy and Poisons Board (PPB) has issued a public safety warning cautioning women against using cetirizine, a commonly prescribed allergy medication, for vaginal tightening or inducing vaginal dryness following the circulation of misleading claims on social media.
In an alert issued on Thursday, November 5, 2026, the regulator clarified that cetirizine is an antihistamine intended for oral use to relieve allergic conditions such as allergic rhinitis, sneezing, itchy skin and urticaria (hives).
The warning follows viral social media discussions, particularly on TikTok, claiming that inserting cetirizine tablets into the vagina can reduce moisture and create a tightening effect.
The Board, through its Chief Executive Officer Dr Ahmed I. Mohamed, dismissed the claims, stating that the medication is neither approved for vaginal application nor supported by scientific evidence for such purposes.
The regulator warned that inserting the tablets into the vagina could cause irritation, burning, soreness, pain and discomfort. It could also interfere with the vagina’s natural protective environment, increasing the risk of infections.
The Pharmaceutical Society of Kenya (PSK) has also cautioned against the practice, explaining that vaginal dryness does not translate into tightening or strengthening of vaginal muscles. The society warned that reduced lubrication could instead increase friction, discomfort and the risk of tissue injury.
Meanwhile, the Ministry of Health is considering introducing a medicine tracking system to monitor the distribution and purchase of cetirizine amid concerns over increased demand and possible shortages.
Medical Services Principal Secretary Dr Ouma Oluga said the proposed system would help authorities trace medicines from manufacturers and distributors to pharmacies and consumers, ensuring pharmaceutical products are used for their intended medical purposes.
The concerns have also been linked to reports of increased demand, price hikes and stock shortages in some pharmacies, potentially affecting patients who rely on the medication for allergy treatment.
The Pharmacy and Poisons Board has urged Kenyans to avoid experimenting with medicines based on unverified social media claims and to use cetirizine strictly as directed by qualified healthcare professionals.
It has also advised women experiencing vaginal dryness or other reproductive health concerns to seek medical guidance rather than relying on online remedies.
